Perkins, Geraldine
Svrcek, Magali
Bouchet-Doumenq, Cecile
Voron, Thibault
Colussi, Orianne
Debove, Clotilde
Merabtene, Fatiha
Dumont, Sylvie
Sauvanet, Alain
Hammel, Pascal
Cros, Jerome
André, Thierry
Bachet, Jean-Baptiste
Bardier, Armelle
Douard, Richard
Meatchi, Tchao
Peschaud, Frederique
Emile, Jean-Francois
Cojean-Zelek, Isabelle
Laurent-Puig, Pierre
Taieb, Julien
Article History
Received: 30 September 2018
Revised: 5 February 2019
Accepted: 13 February 2019
First Online: 6 March 2019
Competing interests
: Geraldine Perkins received a grant from Merck Serono, and reports honoraria from Servier and Sanofi. Thierry André has served in a consulting/advisory role for Roche, Amgen, Bristol-Myers Squibb, and MSD Oncology. Julien Taieb reports honoraria from Amgen, Baxalta, Celgene, Eli Lilly, Merck KGgA, Roche/Genentech, Sanofi, and Servier, and a consultancy or advisory role with Amgen, Baxalta, Celgene, Eli Lilly, Merck KGgA, Roche/Genentech, Sanofi, and Servier. Magali Svrcek, Cecile Bouchet Doumenq, Thibault Voron, Orianne Colussi, Clotilde Debove, Fatiha Merabtene, Sylvie Dumont, Alain Sauvanet, Pascal Hammel, Jerome Cros, Jean-Baptiste Bachet, Armelle Bardier, Richard Douard, Tchao Meatchi, Frederique Peschaud, Jean-Francois Emile, Isabelle Cojean-Zelek and Pierre Laurent-Puig declare no competing interests.
: Data and materials are available on request.
: Acquisition of data and biological material was approved by the Ile-de-France ethics committee number 4. The study was performed in accordance with the Declaration of Helsinki.
: This work was supported in part by ARCAD (Aide et Recherche en Cancérologie Digestive).
: All authors gave final approval on the version to be published.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International.